SCHEMBL23867545

SCHEMBL23867545

CNc1ccc(Nc2cc(C)nc(C)n2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.59
▸ RAB9A P51151 3/20 0.50
▸ CYP1A2 P05177 3/20 0.50
▸ POLB P06746 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ CYP2D6 P10635 1/20 0.49
▸ TP53 P04637 4/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ GBA1 P04062 1/20 0.47
▸ ABCG2 Q9UNQ0 1/20 0.47
▸ APOBEC3A P31941 1/20 0.46
▸ APOBEC3G Q9HC16 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SLC2A1 P11166 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10330598 0.84 RAB9A (0.71) MAPTRAB9ACYP1A2POLBNPC1
SCHEMBL14320027 0.83 CYP1A2 (0.69) MAPTRAB9ACYP1A2POLBNPC1
SCHEMBL23221555 0.80 ABCG2 (0.66) MAPTRAB9ACYP1A2POLBNPC1
SCHEMBL4915813 0.78 NOS3 (0.60) MAPTRAB9APOLBNPC1GAA
SCHEMBL11608377 0.77 CA1 (0.58) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL20354983 0.75 POLB (0.61) MAPTCYP1A2POLBGAACYP3A4
SCHEMBL12218261 0.69 RAB9A (0.76) MAPTRAB9ACYP1A2POLBNPC1
SCHEMBL4012756 0.69 RAB9A (0.71) MAPTRAB9ACYP1A2NPC1GAA
SCHEMBL4212835 0.69 NPC1 (0.58) MAPTRAB9ACYP1A2POLBNPC1
SCHEMBL12218264 0.69 RAB9A (0.76) MAPTRAB9ACYP1A2POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback